A Senate hearing chaired by Rand Paul questions Anthony Fauci about the NIH's new risk-based policy and funding of high-risk research.
6 reports, 5 independent
Updated Aug 17
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 6
- Developments
- 3
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A Senate hearing chaired by Rand Paul questions Anthony Fauci about the NIH's new risk-based policy and funding of high-risk research.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Paul interrogated Fauci regarding NIH support for risky coronavirus research in Wuhan.1 source
- Congressional members investigated Anthony Fauci regarding the use of taxpayer-funded fetal tissue research and NIH compliance.Sub-event
Fauci is questioned about the NIH's new risk-based policy and high-risk research funding.1 source
Keep exploring
The entities involved
-
Anthony Fauci
American immunologist and head of the U.S. National Institute of Allergy and Infectious Diseases
-
National Institutes of Health
government organization in Shah Alam, Malaysia
-
Rand Paul
United States Senator from Kentucky since 2011
Related events
- Allegations surfaced that Anthony Fauci, while leading NIAID, funded gain-of-function research at the Wuhan Institute of Virology.
- Fauci, Bush, and Cheney collaborated to remake NIAID, involving CIA funding and NIH research cover for biodefense programs.
- The National Institutes of Health requires increased federal budget funding, with research demonstrating a potential $2.50 return on investment, discussed alongside U.S. Senator McCormick.
- NIH cuts budgets and personnel, impacting funded research leading to FDA-approved treatments.
- An NIH-funded study in Los Angeles involving Johanna Olson-Kennedy is facing administrative pressure leading to the clinic's closure.